These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11566957)

  • 1. Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives.
    Mosso L; Gómez-Sánchez CE; Foecking MF; Fardella C
    Hypertension; 2001 Sep; 38(3 Pt 2):688-91. PubMed ID: 11566957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
    Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
    Kamrath C; Maser-Gluth C; Haag C; Schulze E
    Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
    Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
    J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.
    Carvajal CA; Campino C; Martinez-Aguayo A; Tichauer JE; Bancalari R; Valdivia C; Trejo P; Aglony M; Baudrand R; Lagos CF; Mellado C; Garcia H; Fardella CE
    Hypertension; 2012 Jan; 59(1):85-91. PubMed ID: 22083159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol.
    Mulatero P; Curnow KM; Aupetit-Faisant B; Foekling M; Gomez-Sanchez C; Veglio F; Jeunemaitre X; Corvol P; Pascoe L
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3996-4001. PubMed ID: 9814482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
    Lee IS; Kim SY; Jang HW; Kim MK; Lee JH; Lee YH; Jo YS
    J Korean Med Sci; 2010 Sep; 25(9):1379-83. PubMed ID: 20808686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Chinese pedigree with glucocorticoid remediable aldosteronism.
    Liu X; Jin L; Zhang H; Ma W; Song L; Zhou X; Cai J
    Hypertens Res; 2021 Nov; 44(11):1428-1433. PubMed ID: 34462604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production.
    Nicod J; Dick B; Frey FJ; Ferrari P
    Mol Cell Endocrinol; 2004 Feb; 214(1-2):167-74. PubMed ID: 15062555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism.
    Litchfield WR; New MI; Coolidge C; Lifton RP; Dluhy RG
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3570-3. PubMed ID: 9360508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
    Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
    J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
    Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism.
    Geller DS; Zhang J; Wisgerhof MV; Shackleton C; Kashgarian M; Lifton RP
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3117-23. PubMed ID: 18505761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation of phenotype in patients with glucocorticoid remediable aldosteronism.
    Gates LJ; MacConnachie AA; Lifton RP; Haites NE; Benjamin N
    J Med Genet; 1996 Jan; 33(1):25-28. PubMed ID: 8825044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the origin of circulating 18-hydroxycortisol and 18-oxocortisol in normal human subjects.
    Freel EM; Shakerdi LA; Friel EC; Wallace AM; Davies E; Fraser R; Connell JM
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4628-33. PubMed ID: 15356073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism.
    Miyamori I; Takeda Y; Takasaki H; Itoh Y; Iki K; Takeda R
    J Endocrinol Invest; 1992 Jan; 15(1):19-24. PubMed ID: 1560187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism.
    Zennaro MC; Jeunemaitre X
    Ann Endocrinol (Paris); 2016 Jul; 77(3):214-9. PubMed ID: 27315758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.
    Mulatero P; di Cella SM; Williams TA; Milan A; Mengozzi G; Chiandussi L; Gomez-Sanchez CE; Veglio F
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3187-91. PubMed ID: 12107222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chimeric CYP11B1/CYP11B2 gene in glucocorticoid-insuppressible familial hyperaldosteronism.
    Ise T; Shimoda A; Takakuwa H; Kato T; Izumiya Y; Shimizu K; Suzuki T; Sasano H; Yokoyama H; Kobayashi K
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):131-4. PubMed ID: 11453962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.